We are international
Donate
TEXT SIZE   


Bortezomib, dexamethasone, cyclophosphamide, lenalidomide (VDCR) has high efficacy in frontline myeloma
By Shaji Kumar, M.D.
XIIth International Myeloma Workshop in Washington, DC
Shaji Kumar, M.D.
Mayo Clinic
Rochester, Minnesota
02.23.09


To view the video full screen, click on the small button next to the volume control in the lower right hand corner.


 related articles